| 序号 |
CAS |
半岛bd体育手机客户端 名称 |
规格 |
包装 |
参考价格 |
| 1 |
|
Carnostatine HCl |
≥98% |
|
询价 |
| 2 |
2071636-15-0 |
Lp-PLA2-IN-2 |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 3 |
15790-94-0 |
trans-2-Undecenoic acid |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 4 |
36840-10-5 |
LPA2 antagonist 2 |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 5 |
178429-65-7 |
Solriamfetol HCl |
≥98% |
|
询价 |
| 6 |
52212-02-9 |
Pipecuronium bromide |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 7 |
111962-89-1 |
RS 49676 |
≥98% |
|
询价 |
| 8 |
2183473-16-5 |
BDP FL-PEG4-TCO |
≥98% |
|
询价 |
| 9 |
308242-62-8 |
Remimazolam |
≥98% |
|
询价 |
| 10 |
154788-16-6 |
PNU-145156E(FCE26644) |
≥98% |
|
询价 |
| 11 |
67200-34-4 |
SMER3 |
≥98% |
|
询价 |
| 12 |
362503-73-9 |
RBC10 |
≥98% |
|
询价 |
| 13 |
163000-63-3 |
Neboglamine |
≥98% |
|
询价 |
| 14 |
1021868-90-5 |
AGN-192403 hydrochloride |
≥98% |
|
询价 |
| 15 |
84-54-8 |
2-Methylanthraquinone |
≥98% |
|
询价 |
| 16 |
686301-48-4 |
NB-001 |
≥98% |
|
询价 |
| 17 |
20380-11-4 |
27-Hydroxycholesterol |
≥98% |
|
询价 |
| 18 |
103412-37-9 |
B 4148 |
≥98% |
|
询价 |
| 19 |
775351-61-6 |
Imeglimin HCl |
≥98% |
|
询价 |
| 20 |
766-20-1 |
1,3-Dioxane,2,4-dimethyl- |
≥98% |
|
询价 |
| 21 |
352439-37-3 |
Amino-PEG8-alcohol |
≥98% |
|
询价 |
| 22 |
53696-70-1 |
Amiclenomycin |
≥98% |
|
询价 |
| 23 |
|
CP4d |
≥98% |
|
询价 |
| 24 |
496-11-7 |
Indan |
≥98% |
|
询价 |
| 25 |
865451-66-7 |
R-1663 |
≥98% |
|
询价 |
| 26 |
480-30-8 |
Dichloralphenazone |
≥98% |
|
询价 |
| 27 |
6415-90-3 |
Atropine hydrobromide |
≥98% |
|
询价 |
| 28 |
20167-22-0 |
AG 307 |
≥98% |
|
询价 |
| 29 |
88192-98-7 |
Myxopyronin A |
≥98% |
|
询价 |
| 30 |
13737-90-1 |
Benzoic acid,5-amino-2-butoxy- |
≥98% |
|
询价 |
| 31 |
|
PGLa TFA |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 32 |
1229238-69-0 |
hDDAH-1-IN-1 |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 33 |
2114339-57-8 |
SAR439859 |
≥98% |
|
询价 |
| 34 |
1464842-09-8 |
M8891 |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 35 |
2196245-16-4 |
Lp-PLA2-IN-3 |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 36 |
145667-75-0 |
Latanoprost Lactone Diol |
≥98% |
|
询价 |
| 37 |
1399880-38-6 |
(R)-Praziquantel D11 |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 38 |
1185241-03-5 |
13-cis Acitretin D3 |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 39 |
1217616-61-9 |
TSHR antagonist S37 |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 40 |
1432061-50-1 |
Nicardipine D3 HCl |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 41 |
98072-47-0 |
Streptolysin O |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 42 |
1005775-56-3 |
TC ASK 10 |
≥98% |
|
询价 |
| 43 |
217480-26-7 |
L-803087 |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 44 |
1246833-26-0 |
Curcumin D6 |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 45 |
96760-69-9 |
Adenosine amine congener |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 46 |
109351-34-0 |
(R)-Terazosin |
≥98% |
|
询价 |
| 47 |
|
Amylin,amide,human TFA |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 48 |
|
CDK ligand for PROTAC HCl |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 49 |
1135306-36-3 |
MJ33-OH lithium |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 50 |
|
BM635 mesylate |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 51 |
|
DC10SMe |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 52 |
1191908-14-1 |
ADRA1D receptor agonist 1 |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 53 |
2138439-53-7 |
(S,R,S)-AHPC-C4-NH2 |
≥98% |
|
询价 |
| 54 |
2097509-36-7 |
Thalidomide-NH-PEG2-C2-NH2 TFA |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 55 |
615538-47-1 |
DC4SMe |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 56 |
1065606-97-4 |
AR453588 HCl |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 57 |
1229238-70-3 |
hDDAH-1-IN-1 TFA |
≥98% |
50mg, 100mg, 250mg |
询价 |
| 58 |
1033767-86-0 |
BAY-474 |
≥98% |
|
询价 |
| 59 |
1631164-24-3 |
BAY-784 |
≥98% |
|
询价 |
| 60 |
|
VU6015929 |
≥98% |
|
询价 |
m.cnreagent.com
